MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

Search

Zoetis Inc

Open

SectorGezondheidszorg

146.7 -0.3

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

146.03

Max

148.65

Belangrijke statistieken

By Trading Economics

Inkomsten

87M

718M

Verkoop

240M

2.5B

K/W

Sectorgemiddelde

24.708

35.739

Dividendrendement

1.3

Winstmarge

29.187

Werknemers

13,800

EBITDA

100M

1.1B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+27.93% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.30%

3.08%

Volgende Winsten

4 nov 2025

Volgende dividenddatum

2 dec 2025

Volgende Ex Dividend datum

30 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-4B

64B

Vorige openingsprijs

147

Vorige sluitingsprijs

146.7

Nieuwssentiment

By Acuity

58%

42%

314 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Zoetis Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 nov 2024, 12:47 UTC

Winsten

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

5 aug 2025, 11:06 UTC

Winsten

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5 aug 2025, 11:06 UTC

Winsten

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5 aug 2025, 11:05 UTC

Winsten

Zoetis 2Q Adj EPS $1.76 >ZTS

6 mei 2025, 11:14 UTC

Winsten

Zoetis Sees FY25 Adj EPS $6.20-Adj EPS $6.30 >ZTS

6 mei 2025, 11:14 UTC

Winsten

Zoetis Sees FY25 Rev $9.43B-$9.58B >ZTS

6 mei 2025, 11:13 UTC

Winsten

Zoetis 1Q Adj EPS $1.48 >ZTS

6 mei 2025, 11:00 UTC

Winsten

Zoetis 1Q Net $631M >ZTS

6 mei 2025, 11:00 UTC

Winsten

Zoetis 1Q Rev $2.22B >ZTS

6 mei 2025, 11:00 UTC

Winsten

Zoetis 1Q EPS $1.41 >ZTS

20 feb 2025, 08:00 UTC

Top Nieuws

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13 feb 2025, 13:47 UTC

Winsten

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13 feb 2025, 12:09 UTC

Winsten

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13 feb 2025, 12:08 UTC

Winsten

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13 feb 2025, 12:08 UTC

Winsten

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13 feb 2025, 12:00 UTC

Winsten

Zoetis 4Q EPS $1.29 >ZTS

13 feb 2025, 12:00 UTC

Winsten

Zoetis 4Q Rev $2.32B >ZTS

13 feb 2025, 12:00 UTC

Winsten

Zoetis 4Q Net $581M >ZTS

4 nov 2024, 14:05 UTC

Winsten

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

4 nov 2024, 12:06 UTC

Winsten

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

4 nov 2024, 12:06 UTC

Winsten

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

4 nov 2024, 12:05 UTC

Winsten

Zoetis 3Q Adj EPS $1.58 >ZTS

4 nov 2024, 12:00 UTC

Winsten

Zoetis 3Q Net $682M >ZTS

4 nov 2024, 12:00 UTC

Winsten

Zoetis 3Q EPS $1.50 >ZTS

4 nov 2024, 12:00 UTC

Winsten

Zoetis 3Q Rev $2.39B >ZTS

Peer Vergelijking

Prijswijziging

Zoetis Inc Prognose

Koersdoel

By TipRanks

27.93% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 187.4 USD  27.93%

Hoogste 221 USD

Laagste 153 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zoetis Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

8

Buy

3

Hold

0

Sell

Technische score

By Trading Central

152.58 / N/ASteun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

314 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat